Expression of survivin protein in pterygium and relationship with oxidative DNA damage

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 6A, 2008, Pages 2372-2380

  Maxia, C ^a   Perra, M T ^a   Demurtas, P ^a   Minerba, L ^a   Murtas, D ^a   Piras, F ^a   Corbu, A ^b   Gotuzzo, D C ^c   Cabrera, R G ^c   Ribatti, D ^d   Sirigu, P ^a,e  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSIDAD DE CUENCA   (Ecuador)

^d UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^e Instituto del Cancer 'Solca'   (Ecuador)

Author keywords

Immunohistochemistry; Oxidative stress; Pterygium; Survivin

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; BIRC5 PROTEIN, HUMAN; DEOXYGUANOSINE; DRUG DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; DNA DAMAGE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOLOGY; PTERYGIUM; ULTRAVIOLET RADIATION;

ADULT; AGED; APOPTOSIS; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; OXIDATION-REDUCTION; PTERYGIUM; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 53049090999     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00256.x     Document Type: Article

References (57)

1. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol. 1999 6 : 219 28.
2. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999 10 : 282 8.
3. Detorakis ET, Drakonaki EE, Spandidos DA. Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med 2000 6 : 35 41.
4. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol. 2000 84 : 212 6.
5. Sakoonwatanyoo P, Tan DT, Smith DR. Expression of p63 in pterygium and normal conjunctiva. Cornea. 2004 23 : 67 70.
6. Di Girolamo N, Kumar RK, Coroneo MT, Wakefield D. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2002 43 : 3430 7.
7. Nolan TM, DiGirolamo N, Sachdev NH, Hampartzoumian T, Coroneo MT, Wakefield D. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol. 2003 162 : 567 74.
8. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 1998 236 : 702 8.
9. Liu Z, Xie Y, Zhang M. Overexpression of type I growth factor receptors in pterygium. Chin Med J. 2002 115 : 418 21.
10. Van Setten G, Aspiotis M, Blalock TD, Grotendorst G, Schultz G. Connective tissue growth factor in pterygium: simultaneous presence with vascular endothe-lial growth factor - possible contributing factor to conjunctival scarring. Graefes Arch Clin Exp Ophthalmol. 2003 241 : 135 9.
11. Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A, Herbert M, Bar-Dayan Y. Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res. 2002 25 : 17 22.
12. Ribatti D, Nico B, Maxia C, Longo V, Murtas D, Mangieri D, Perra MT, De Giorgis M, Piras F, Crivellato E, Sirigu P. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J. Cell. Mol. Med. 2007 11 : 585 9.
13. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000 41 : 671 9.
14. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol. 1984 98 : 225 8.
15. Perra MT, Maxia C, Zucca I, Piras F, Sirigu P. Immunohistochemical study of human pterygium. Hlstol Hlstopathol. 2002 17 : 139 49.
16. Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea. 2001 20 : 164 7.
17. Gallagher MJ, Giannoudis A, Herrington CS, Hiscott P. Human papillomavirus in pterygium. Br J Ophthalmol. 2001 85 : 782 4.
18. Piras F, Moore PS, Ugalde J, Perra MT, Scarpa A, Sirigu P. Detection of human papillomavirus DNA in pterygia from different geographical regions. BrJ Ophthalmol. 2003 87 : 864 6.
19. Clear AS, Chirambo MC, Hutt MS. Solar keratosis, pterygium, and squamous cell carcinoma of the conjunctiva in Malawi. Br J Ophthalmol. 1979 63 : 102 9.
20. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingueculae: pterygia, and limbal tumors. Curr Eye Res 1997 16 : 1179 92.
21. Tan DT, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol. 1997 123 : 404 5.
22. Perra MT, Colombari R, Maxia C, Zucca I, Piras F, Corbu A, Bravo S, Scarpa A, Sirigu P. Finding of conjunctival melanocytic pigmented lesions within pterygium. Hlstopathology. 2006 48 : 387 93.
23. Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: a positive correlation. BrJ Ophthalmol. 1984 68 : 343 6.
24. Mackenzie FD, Hirst LW, Battistutta D, Green A. Risk analysis in the development of pterygia. Ophthalmology. 1992 99 : 1056 61.
25. Cullen AP. Photokeratitis and other photo-toxic effects on the cornea and conjunctiva. Int J Toxicol. 2002 21 : 455 64.
26. Kau HC, Tsai CC, Lee CF, Kao SC, Hsu WM, Liu JH, Wei YH. Increased oxidative DNA damage, 8-hydroxydeoxy- guanosine, in human pterygium. Eye. 2006 20 : 826 31.
27. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol. 2005 32 : 191 205.
28. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T. UV-induced skin damage. Toxicology. 2003 189 : 21 39.
29. Aziz MH, Ghotra AS, Shukla Y, Ahmad N. Ultraviolet-B radiation causes an upregula-tion of survivin in human keratinocytes and mouse skin. Photochem Photobiol. 2004 80 : 602 8.
30. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med. 2001 7 : 542 7.
31. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apopto-sis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998 58 : 5071 4.
32. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N. Engl. J. Med. 1999 341 : 452 3.
33. Colnaghi R, Connell CM, Barrett RM, Wheatley SP. Separating the anti-apoptot-ic and mitotic roles of survivin. J Biol Chem. 2006 281 : 33450 6.
34. Noton EA, Colnaghi R, Tate S, Starck C, Carvalho A, Ko Ferrigno P, Wheatley SP. Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem. 2006 281 : 1286 95.
35. Zaffaroni N, Pennati M, Colella G, Perego P, Supino R, Gatti L, Pilotti S, Zunino F, Daidone MG. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Lite Sci. 2002 59 : 1406 12.
36. Giannetti L, Console U, Magnoni C, Lo Muzio L. Apoptosis: escaping strategies in human skin cancer. Oncol Rep. 2004 11 : 401 5.
37. Buron N, Micheau O, Cathelin S, Lafontaine PO, Creuzot-Garcher C, Solary E. Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride. Invest Ophthalmol Vis Sci. 2006 47 : 4221 30.
38. Grossman D, McNiff JM, Li F, Altieri DC. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest. 1999 79 : 1121 6.
39. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, Pincelli C. Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol. 1999 113 : 415 8.
40. Park HR, Min SK, Cho HD, Kim KH, Shin HS, Park YE. Expression profiles of p63: p53, survivin, and hTERT in skin tumors. J Cutan Pathol. 2004 31 : 544 9.
41. Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006 5 : 1087 98.
42. Perra MT, Maxia C, Corbu A, Minerba L, Demurtas P, Colombari R, Murtas D, Bravo S, Piras F, Sirigu P. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol Vis. 2006 12 : 1136 42.
43. Nishigori C. Cellular aspects of photocar-cinogenesis. Photochem Photobiol Sci. 2006 5 : 208 14.
44. Calderon-Garciduenas L, Wen-Wang L, Zhang YJ, Rodriguez-Alcaraz A, Osnaya N, Villarreal-Calderon A, Santella RM. 8-hydroxy-2'-deoxyguanosine, a major mutagenic oxidative DNA lesion, and DNA strand breaks in nasal respiratory epithelium of children exposed to urban pollution. Environ Health Perspect. 1999 107 : 469 74.
45. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog. 1991 4 : 196 202.
46. Hattori Y, Nishigori C, Tanaka T, Uchida K, Nikaido O, Osawa T, Hiai H, Imamura S, Toyokuni S. 8-hydroxy-2'-deoxyguano-sine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol. 1996 107 : 733 7.
47. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997 88 : 323 31.
48. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002 2 : 594 604.
49. Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Chang KC. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis. 2005 11 : 50 5.
50. Schneider BG, John-Aryankalayil M, Rowsey JJ, Dushku N, Reid TW. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. ExpEyeRes. 2006 82 : 91 8.
51. Giebel J, Woenckhaus C, Fabian M, Tost F. Age-related differential expression of apoptosis-related genes in conjunctival epithelial cells. Ada Ophthalmol Scand. 2005 83 : 471 6.
52. Li F, Ling X. Survivin study: an update of "what is the next wave"? J Cell Physiol. 2006 208 : 476 86.
53. Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest. 2004 114 : 1117 27.
54. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chein. 2002 277 : 3247 57.
55. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S. Human survivin is neg-atively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene. 2002 21 : 2613 22.
56. Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW. DNA damage induces a novel p53-survivin signalling pathway regulating cell cycle and apoptosis in acute lym-phoblastic leukemia cells. J Pharmacol Exp Ther. 2002 303 : 124 31.
57. Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med. 2007 85 : 1175 86.